Anthony B Evnin has bought stock on 5 days since Mar 2017

Anthony B. Evnin, Ph.D. is a biopharmaceutical industry pioneer, longtime venture capitalist, and corporate director who has served as a Director of Cantel Medical Corp (CMD), where he sat on the board during the company’s growth as a medical technology business.( He has been a partner at Venrock, the venture capital firm founded by the Rockefeller family, since 1974, where he established and led the firm’s healthcare franchise and helped shape the modern biotechnology industry by backing companies such as Centocor, IDEC Pharmaceuticals, Infinity Pharmaceuticals, Genetics Institute, IDEXX Laboratories, Athena Neurosciences, and Acceleron Pharma.( In addition to his Cantel Medical role, he has held board positions with numerous life science and medical technology companies, including Infinity Pharmaceuticals, Juno Therapeutics, AVEO Pharmaceuticals, Constellation Pharmaceuticals, and many others.(

Evnin began his career as a research scientist and group leader in organic chemistry at Union Carbide, later serving as director of product development at Story Chemical before transitioning into venture investing.( He holds an A.B. in chemistry from Princeton University (1962) and a Ph.D. in chemistry from the Massachusetts Institute of Technology (1966).( Beyond his corporate roles, he has been deeply engaged in biomedical and academic governance, serving in leadership and board roles at institutions including the Albert and Mary Lasker Foundation, Memorial Sloan Kettering Cancer Center, The Jackson Laboratory, the New York Genome Center, Rockefeller University, and Princeton University, and he received a Lifetime Achievement Award from the National Venture Capital Association in 2009.(

Written by Perplexity from public sources.